Consensus Haemonetics Corporation

Equities

HAE

US4050241003

Market Closed - Nyse Other stock markets 04:00:02 2024-06-13 pm EDT			5-day change	1st Jan Change
86.05 ^USD	+0.14%		-1.52%	+0.63%

Jun. 12	Haemonetics Shares Rise After Upgrade From Needham	MT
Jun. 12	Needham Upgrades Haemonetics to Buy From Hold, Sets Price Target at $112	MT

Evolution of the average Target Price on Haemonetics Corporation

Price target over the last 5 years

History of analyst recommendation changes

dbe4a6d863ab56.TV1kdkA-0OYtrWL43GT9KPd-rf_sr9BWr75u1_qnVUM.IRsgNy0LnoFpmBG_nQKWR6M374WL_qE_mvAv757yOBYlNgBEEXqYsGj3BQ~f2cc5214a8410a172e62102f165df627

Analyst Recommendations on Haemonetics Corporation

Haemonetics Shares Rise After Upgrade From Needham	Jun. 12	MT
Needham Upgrades Haemonetics to Buy From Hold, Sets Price Target at $112	Jun. 12	MT
Haemonetics Insider Sold Shares Worth $1,144,208, According to a Recent SEC Filing	May. 29	MT
Haemonetics Insider Sold Shares Worth $775,253, According to a Recent SEC Filing	May. 29	MT
Haemonetics Insider Sold Shares Worth $254,443, According to a Recent SEC Filing	May. 21	MT
Barrington Research Raises Price Target on Haemonetics to $107 From $105, Keeps Outperform Rating	May. 10	MT
Barrington Cuts Price Target on Haemonetics to $105 From $114 on 'Macro Concerns', Keeps Outperform Rating	Nov. 03	MT
Citigroup Raises Haemonetics' Price Target to $94 From $90, Keeps Neutral Rating	23-10-02	MT
Barrington Raises Price Target on Haemonetics to $114 From $111, Keeps Outperform Rating	23-08-09	MT
Morgan Stanley Adjusts Price Target on Haemonetics to $96 From $88, Maintains Equal-Weight Rating	23-05-12	MT
Barrington Ups Price Target on Haemonetics to $111 From $103, Keeps Outperform Rating	23-05-12	MT
JMP Securities Adjusts Price Target on Haemonetics to $115 From $105, Maintains Market Outperform Rating	23-05-12	MT
Morgan Stanley Raises Haemonetics' Price Target to $88 From $84, Maintains Equalweight Rating	23-02-08	MT
Mizuho Securities Adjusts Price Target on Haemonetics to $115 From $110, Maintains Buy Rating	23-02-08	MT
Citigroup Raises Haemonetics' Price Target to $95 From $92, Maintains Neutral Rating	23-02-08	MT
Barrington Research Raises Haemonetics' Price Target to $103 From $94, Maintains Outperform Rating	23-02-08	MT
Mizuho Adjusts Haemonetics' Price Target to $110 From $100, Keeps Buy Rating	23-01-24	MT
Morgan Stanley Cuts Price Target on Haemonetics to $84 From $90, Reiterates Equalweight Rating	23-01-06	MT
Citigroup Boosts Price Target on Haemonetics to $92 From $88, Affirms Neutral Rating	22-12-12	MT
Citigroup Adjusts Price Target on Haemonetics to $88 From $80, Maintains Neutral Rating	22-11-08	MT
Barrington Hikes Price Target for Haemonetics to $94 From $88, Keeps Outperform Rating	22-11-08	MT
Morgan Stanley Adjusts Price Target on Haemonetics to $90 From $85, Maintains Equalweight Rating	22-11-08	MT
Raymond James Adjusts Price Target on Haemonetics to $100 From $88, Maintains Outperform Rating	22-11-08	MT
JMP Securities Adjusts Price Target on Haemonetics to $105 From $90, Maintains Market Outperform Rating	22-11-08	MT
Mizuho Adjusts Price Target on Haemonetics to $100 From $90, Maintains Buy Rating	22-11-08	MT